Back to User profile » Dr Njira Lugogo
Papers published by Dr Njira Lugogo:
Mortality Among Adults with Subspecialist-Treated Severe Asthma: A Descriptive Analysis from the Observational CHRONICLE Study
Lugogo NL, Trevor J, Spahn JD, Panettieri RA Jr, Carstens DD, Ambrose CS
Journal of Asthma and Allergy 2026, 19:588118
Published Date: 5 May 2026
Disease Burden of Asthma Patients Utilizing Short-Acting Beta-2 Agonist-Only Inhalers as Rescue in the United States
Lugogo N, Moon RC, Chung Y, David J, Motawakel O, Rosenthal NA, Skolnik N
Journal of Asthma and Allergy 2026, 19:564966
Published Date: 14 January 2026
Novel Real-World Insights Into Tezepelumab Effectiveness in Steroid-Dependent Asthma
Aslam MMS, Senn R, Bagheri A, Harwood H, Troost JP, Lugogo NL, Mohan A
Journal of Asthma and Allergy 2025, 18:1835-1839
Published Date: 18 December 2025
Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action
Lindsley AW, Lugogo N, Reeh KAG, Spahn J, Parnes JR
Journal of Asthma and Allergy 2025, 18:33-57
Published Date: 14 January 2025
Reduced Effectiveness of Anti-IgE Treatment Among Adults with Severe Asthma with Older Age of Asthma Onset: Results from the CHRONICLE Study
Ledford DK, Carr WW, Moore WC, Lugogo NL, Mohan A, Chipps B, Mackie AR, Lindsley AW, Spahn J, Ambrose CS
Journal of Asthma and Allergy 2024, 17:977-982
Published Date: 9 October 2024
Patterns of Rescue and Maintenance Medication Claims Surrounding an Asthma Exacerbation in Patients Treated as Intermittent or Mild Persistent Asthma
Lanz MJ, Pollack M, Gilbert IA, Gandhi HN, Tkacz JP, Lugogo NL
Journal of Asthma and Allergy 2024, 17:871-877
Published Date: 14 September 2024
Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry
Lugogo NL, Heffler E, Plaza V, Hilberg O, Xia C, Nash S, Pandit N, Jacob-Nara JA, Sacks HJ, Rowe PJ, Deniz Y, Hardin M, Soler X
Journal of Asthma and Allergy 2024, 17:551-556
Published Date: 6 June 2024
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types
Panettieri R Jr, Lugogo N, Corren J, Ambrose CS
Journal of Asthma and Allergy 2024, 17:219-236
Published Date: 19 March 2024
Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma
Gurnell M, Radwan A, Bachert C, Lugogo N, Cho SH, Nash S, Zhang H, Khan AH, Jacob-Nara JA, Rowe PJ, Deniz Y
Journal of Asthma and Allergy 2024, 17:1-8
Published Date: 16 January 2024
Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist–Inhaled Corticosteroid Rescue
Lugogo N, Gilbert I, Pollack M, Gandhi H, Tkacz J, Lanz MJ
Journal of Asthma and Allergy 2023, 16:579-584
Published Date: 31 May 2023
Long-Term Use of Maintenance Systemic Corticosteroids is Associated with Multiple Adverse Conditions in a Large, Real-World Cohort of US Adults with Severe Asthma
Lugogo N, Chipps BE, Panettieri RA Jr, Trudo F, Ambrose CS
Journal of Asthma and Allergy 2022, 15:1753-1761
Published Date: 7 December 2022
A Predictive Machine Learning Tool for Asthma Exacerbations: Results from a 12-Week, Open-Label Study Using an Electronic Multi-Dose Dry Powder Inhaler with Integrated Sensors
Lugogo NL, DePietro M, Reich M, Merchant R, Chrystyn H, Pleasants R, Granovsky L, Li T, Hill T, Brown RW, Safioti G
Journal of Asthma and Allergy 2022, 15:1623-1637
Published Date: 11 November 2022
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
Menzies-Gow AN, McBrien C, Unni B, Porsbjerg CM, Al-Ahmad M, Ambrose CS, Dahl Assing K, von Bülow A, Busby J, Cosio BG, FitzGerald JM, Garcia Gil E, Hansen S, Heaney LG, Hew M, Jackson DJ, Kallieri M, Loukides S, Lugogo NL, Papaioannou AI, Larenas-Linnemann D, Moore WC, Perez-de-Llano LA, Rasmussen LM, Schmid JM, Siddiqui S, Alacqua M, Tran TN, Suppli Ulrik C, Upham JW, Wang E, Bulathsinhala L, Carter VA, Chaudhry I, Eleangovan N, Murray RB, Price CA, Price DB
Journal of Asthma and Allergy 2022, 15:63-78
Published Date: 13 January 2022
Demographics, Treatment Patterns, and Morbidity in Patients with Exercise-Induced Bronchoconstriction: An Administrative Claims Data Analysis
Lanz MJ, Gilbert IA, Gandhi HN, Goshi N, Tkacz JP, Lugogo NL
Journal of Asthma and Allergy 2021, 14:1485-1495
Published Date: 11 December 2021
The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results
Ambrose CS, Chipps BE, Moore WC, Soong W, Trevor J, Ledford DK, Carr WW, Lugogo N, Trudo F, Tran TN, Panettieri RA Jr
Pragmatic and Observational Research 2020, 11:77-90
Published Date: 16 July 2020